Screener
InflaRx N.V.
IFRXInflaRx N.V. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Niels C. Riedemann, with a market cap of $356.6M.
$356.63M+426%
We’re still putting together InflaRx N.V.’s detailed financials. Its latest earnings are below. You’ll find its full filings on SEC EDGAR, or explore the companies we cover.
Ask us to move InflaRx N.V. up the queue, and we’ll analyze its filings next.
Earnings
Next report
Nov 9, 2026 (in 2 months)Revenue estimate$6.1K
EPS estimate-$0.07
Profile
CountryGermany
Listed2017
Employees66.0
CEONiels C. Riedemann
SectorHealthcare
IndustryBiotechnology
Websiteinflarx.de
FilingsSEC EDGAR